Welcome to the IPC Psoriasis Masterclass for Asia, an exclusive educational opportunity for early- to mid-career dermatologists and other healthcare professionals actively managing and treating psoriasis.
This Masterclass is led by an esteemed faculty of international experts boasting extensive experience in psoriasis care. We aim to equip attendees with cutting-edge skills and knowledge to elevate their careers and become leaders in psoriasis.
IPC will provide travel stipends of $200 for local attendees and $500 for attendees traveling internationally.
Schedule:
Thursday, October 8
19:00–20:30 – Welcome Reception
Friday, October 9
08:00 – Program Begins
17:30 – Program Ends
The Masterclass is limited to 50 participants, selected from those dedicated to advancing their expertise in managing and treating psoriasis. If you are a Dermatologist, Dermatology Resident, or other healthcare provider from Asia with a solid background in dermatology, this program is designed for you.
Brief Summary of the Course
The IPC Psoriasis Masterclass for Asia is an intensive, eight-hour educational program designed for early-to-mid-career dermatologists and healthcare professionals interested in specializing in psoriasis care. With a focus on fostering a small group environment, the Masterclass provides a personalized learning experience, empowering participants to excel in their careers and become leaders in psoriasis.
The agenda has been carefully designed to ensure participants gain the skills and knowledge required to manage patients effectively. Participants will engage in dynamic discussions, interactive Q&A sessions, and invaluable networking opportunities with distinguished experts in the field.
Learning Outcomes
Topics Covered
Prerequisites
The IPC Psoriasis Masterclass is for early-mid career dermatologists and other health professionals with a strong foundation in dermatology who are making treatment decisions and managing patients with psoriasis.
REGISTRATION – 07:30
WELCOME + INTRODUCTION
Akimichi Morita, MD, PhD, Japan
Global and Regional Disease Burden of Psoriasis
Unveiling the Pathogenesis and Phenotypes of Psoriasis: A Bridge to Personalized Care
Psoriasis as a Systemic Disease
How to Assess Disease Severity and Treatment Outcomes in Clinical Practice
BREAK
Psoriatic Arthritis for Dermatologists
Generalized Pustular Psoriasis
Optimizing the Use of Topicals and Oral Therapies
Phototherapy: Current Use and Developments
LUNCH
Optimizing the Use of Biologics and Biosimilars
Psoriasis in Special Populations & Circumstances
Faculty Forum: Challenging Cases
Challenging Cases Workshop – Presented by Delegates
Panel Discussion and Q&A
BREAK
New and Emerging Treatments for Psoriasis
Integrating the Lessons from the Masterclass
Closing Comments
Okinawa Convention Center
4 Chome-3-1 Mashiki, Ginowan,
Okinawa 901-2224, Japan
Conference Room 2F B1
Travel Scholarship
To help support participation, IPC will provide travel stipends of $200 for local attendees and $500 for attendees traveling internationally. Travel Scholarships will be distributed after the close of the Masterclass.
Transportation
Participants are responsible for arranging and covering the cost of their air travel, ground transportation, and accommodations. We recommend booking flights well in advance to secure the best rates and to ensure your travel plans allow for full participation in the program.
The nearest airport to the venue, Okinawa Convention Center, is the Naha International Airport.
Meals
An evening reception with hors d’oeuvres and drinks will be held on Thursday, October 8, at the Laguna Garden Hotel Okinawa. Refreshments during breaks and lunch will be provided on Friday, October 9.
IPC Councilor Helen Young provides commentary on a study identifying skin-derived myeloid precursors and CD200+ fibroblasts as key drivers of psoriatic disease spread from the skin to joints, highlighting the CD200–CD200R1 axis as a promising therapeutic target.
IPC Fellow Dr. Yemsrach Abawaji shares her firsthand perspective on the barriers to psoriasis diagnosis and treatment in Ethiopia and opportunities to improve care.
Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.
Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.
